Mayne Pharma Group Limited (ASX:MYX)

Mayne Pharma Group Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	185	406	383	367	441	565
Market Cap Growth	-68.46%	6.16%	4.25%	-16.81%	-21.88%	-12.64%
Enterprise Value	160	321	264	273	717	791
Last Close Price	2.28	5.00	4.71	4.40	4.40	5.63
PE Ratio	-	-	-	3.13	-	-
PS Ratio	0.46	1.00	0.99	2.00	2.81	1.41
PB Ratio	0.53	1.10	0.84	0.58	0.82	0.73
P/TBV Ratio	-	-	-	19.18	3.46	-
P/FCF Ratio	12.40	78.23	-	-	-	13.52
P/OCF Ratio	8.56	23.25	-	-	-	9.59
PEG Ratio	-	2.29	2.29	2.29	2.29	2.29
EV/Sales Ratio	0.39	0.79	0.68	1.49	4.56	1.97
EV/EBITDA Ratio	5.30	7.63	-	-	-	15.81
EV/FCF Ratio	10.73	61.85	-	-	-	18.94
Debt / Equity Ratio	0.12	0.11	0.09	0.08	0.77	0.45
Debt / EBITDA Ratio	1.40	0.90	-	-	-	6.53
Debt / FCF Ratio	2.84	7.95	-	-	-	8.33
Net Debt / Equity Ratio	-0.07	-0.16	-0.24	-0.27	0.59	0.32
Net Debt / EBITDA Ratio	-0.93	-1.40	7.62	1.48	-6.81	4.99
Net Debt / FCF Ratio	-1.67	-11.39	4.75	3.38	-18.34	5.98
Asset Turnover	0.39	0.38	0.33	0.14	0.11	0.24
Inventory Turnover	2.80	2.57	2.16	1.05	0.81	2.23
Quick Ratio	1.01	1.08	1.03	1.38	0.61	1.31
Current Ratio	1.33	1.35	1.33	1.78	0.81	1.87
Return on Equity (ROE)	-20.58%	-21.85%	-30.98%	-54.14%	-33.61%	-23.05%
Return on Assets (ROA)	-2.30%	-1.28%	-4.07%	-9.04%	-5.57%	-0.47%
Return on Invested Capital (ROIC)	-11.65%	-6.73%	-19.33%	-27.89%	-13.07%	-1.07%
Return on Capital Employed (ROCE)	-5.60%	-2.90%	-9.80%	-19.60%	-18.60%	-1.00%
Earnings Yield	-44.93%	-23.10%	-45.53%	31.94%	-63.75%	-36.91%
FCF Yield	8.06%	1.28%	-6.08%	-13.91%	-3.90%	7.40%
Payout Ratio	-	-	-	38.63%	-	-
Buyback Yield / Dilution	-0.43%	0.60%	3.11%	0.15%	-4.74%	-2.75%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.